行情

XBIT

XBIT

XBiotech
NASDAQ

实时行情|Nasdaq Last Sale

9.59
-0.11
-1.13%
已收盘, 16:00 09/16 EDT
开盘
9.70
昨收
9.70
最高
9.90
最低
9.48
成交量
10.94万
成交额
--
52周最高
11.74
52周最低
2.520
市值
3.93亿
市盈率(TTM)
-15.2102
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

XBIT 新闻

  • 苹果140亿美元上诉案开庭:称欧盟滥用职权 违背常识
  • 新浪科技.2小时前
  • 瑞银:港交所可以尝试号召伦交所股东召开临时大会
  • 新浪财经.2小时前
  • 美交通部宣布首批自动驾驶研究补助金去向 三州入围
  • TechWeb.3小时前
  • 亚马逊被曝“做手脚”推销其高利润率产品
  • 澎湃新闻.3小时前

更多

所属板块

生物技术和医学研究
+0.97%
制药与医学研究
-0.15%

热门股票

名称
价格
涨跌幅

XBIT 简况

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).
展开

Webull提供XBiotech Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。